Results 181 to 190 of about 5,766,482 (313)

A new predictor of disease activity in Takayasu's arteritis patients: pericarotid fat density. [PDF]

BMC Med Imaging
Lan Y, Xie Z, Li D, Dang Y, Sun L, Ma H, Hou Y.   +6 more
europepmc   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Periodontal Status and Disease Activity in Psoriatic Arthritis and Psoriasis: A Cross-Sectional Study. [PDF]

Arch Rheumatol
Akyuz B, Durmus H, Baytımur H, Tomay Aksoy O, Basak G, Daltaban O, Alpsoy E, Sezer İ, Kacar C.   +8 more
europepmc   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Correction: The Regulate your Sitting Time (RESIT) intervention for reducing sitting time in individuals with type 2 diabetes: findings from a randomised-controlled feasibility trial

Diabetology & Metabolic Syndrome
Marsha L. Brierley, Angel M. Chater, Charlotte L. Edwardson, Ellen M. Castle, Emily R. Hunt, Stuart J. H. Biddle, Rupa Sisodia, Daniel P. Bailey   +7 more
doaj   +1 more source

Integrated structural and functional brain imaging reveals biomarkers of disease activity in Crohn's disease. [PDF]

BMC Gastroenterol
Bao C, Xu S, Wu L, Zhu X, Wang D, Zhang Z, Qu C, Shi Y, Zeng X, Zhong J, Zhang J, Wang S, Zheng R, Jin X, Wang H, Liu H, Wu H.   +16 more
europepmc   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Serum Oncostatin M in Ulcerative Colitis Patients and Its Relation to Disease Activity. [PDF]

Int J Mol Sci
Jucan AE, Sarbu GE, Mihai VC, Atodiresei C, Juncu S, Mihai IR, Pavel-Tanasa M, Constantinescu D, Dranga M, Nedelciuc O, Iosep DG, Danciu M, Diaconescu S, Gîlca-Blanariu GE, Andronic AM, Toader E, Drug VL, Prelipcean CC, Mihai C.   +18 more
europepmc   +1 more source

Active crohn disease

, 2021
openaire   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source